ARCHIVES

NIH Extramural Office Lists Initiatives For Reinvention

This article is from The Cancer Letter archive.

Vol. 21 No. 02 | January 13, 1995

Download PDF Visit The Full Archive

Related Articles

FDA Told To Drop Guidelines, But Remains Unmoved On New Drug Delays

December 5, 1975

NIGMS Hosts Meeting On Increasing Minorities In Biomedical Careers

December 1, 1995

ASCO Recommends Aromatase Inhibitors As Adjuvant For Some Breast Cancer

July 30, 2010

CMS Launches National Coverage Analysis, Citing FDA’s Black Box Warning on ESAs.

March 16, 2007

In Brief: Bertino Moves To MSK As Head Of Chemotherapy Research; Rosemary Clive Laves ACOS For Elm

January 2, 1987

President Signs Interim Money Bill; NCI At $725 Million

July 4, 1975